In vitro induction of apoptosis for nasal angiocentric natural killer cell lymphoma-derived cell line, NK-YS, by etoposide and cyclosporine A

British Journal of Haematology

Volumn 113, Issue 4, 2001, Pages 1009-1014

  Uno, Masatoshi ^d   Tsuchiyama, Junjiroh ^a   Moriwaki, Akiyoshi ^b   Noguchi, Toshio ^b   Mizoguchi, Kazuhiro ^c   Ogino, Tetsuya ^b   Yoshino, Tadashi ^b   Okada, Shigeru ^b   Harada, Mine ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

^d NONE

Author keywords

Chemotherapy; Cyclosporine A; Drug resistance; NK cell; P glycoprotein

Indexed keywords

CYCLOSPORIN A; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; PREDNISOLONE; PROTEIN BCL 2; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOMA; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CYCLOSPORINE; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; NUCLEIC ACID SYNTHESIS INHIBITORS; P-GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034930670     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02844.x     Document Type: Article

References (35)

1. High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
2. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients
3. Polymorphic reticulosis, lymphomatoid granulomatosis: Two disease or one?
4. CD3-CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance
5. Apoptosis in cancer therapy: Crossing the threshold
6. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells
7. Apoptosis and the dilemma of cancer chemotherapy
8. Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma
9. Effect of bcl-2 on Fas antigen-mediated cell death
10. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas
11. Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus
12. Nasal natural killer (NK) cell lymphoma: Report of a case with activated NK cells containing Epstein-Barr virus and expressing CD21 antigen, and comparative studies of their phenotype and cytotoxicity with normal NK cells
13. Midline malignant reticulosis (so-called lethal midline granuloma)
14. Participation of p53 protein in the cellular response to DNA damage
15. Selection for drug resistance results in resistance to Fas-mediated apoptosis
16. Treatment outcome and prognostic factors for primary nasal lymphoma
17. Lymphomatoid granulomatosis
18. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
19. p53 is required for radiation-induced apoptosis in mouse thymocytes
20. Tumor suppressor p53 is a regulator of bc12 and bax gene expression in vitro and in vivo
21. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
22. Regulation of apoptosis by bc1-2 family proteins and its role in cancer and chemoresistance
23. Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporine A in blast cells from patients with previously untreated acute myeloid leukemia
24. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response
25. Control of programmed cell death in normal and leukemic cells: New implications for therapy
26. Relief of p53-mediated transcriptional repression by the adenovirus ElB 19-kDa protein or the cellular bcl-2 protein
27. Cyclosporine A reverse vincristine and daunorubicin resistance in acute lymphocytic leukemia in vitro
28. Clinical modulation of multidrug resistance in multiple myeloma: Effect of cyclosporine on resistant tumor cells
29. Murine spleen stromal cell line SPY3-2 maintains long-term hematopoiesis in vitro
30. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Bart virus infection
31. Involvement of the bcl-2 gene in human follicular lymphoma
32. Toward an understanding of the molecular mechanisms of physiological cell death
33. Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance
34. Expression of multidrug resistance P-glycoprotein on peripheral blood mononuclear cells of patients with granular lymphocyte-proliferative disorders
35. A cell killing monoclonal antibody (anti Fas) to cell surface antigen co-down regulated with receptor of tumor necrosis factor